Alyeska Investment Group, L.P. Novo Nordisk A S Transaction History

Alyeska Investment Group, L.P.

$25 Billion
Q4 2024

A detailed history of Alyeska Investment Group, L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 209,866 shares of NVO stock, worth $18.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

209,866

Previous 817,885 74.34%

Holding current value

$18.7 Million

Previous $97.4 Million 81.46%

% of portfolio

0.07%

Previous 0.54%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $51.7 Million - $73 Million	-608,019 Reduced 74.34%	209,866 $18.1 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $66.8 Million - $81.6 Million	560,893 Added 218.25%	817,885 $97.4 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $31.5 Million - $37.8 Million	256,992 New	256,992 $36.7 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $8.18 Million - $10.8 Million	-79,719 Reduced 17.04%	388,090 $52.5 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $49.2 Million - $60.4 Million	-516,144 Reduced 52.46%	467,809 $46.6 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $8.62 Million - $10.2 Million	83,497 Added 9.27%	983,953 $110 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $40.5 Million - $48.9 Million	434,841 Added 93.39%	900,456 $100 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $152,545 - $186,274	1,591 Added 0.34%	465,615 $52.1 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $23.7 Million - $30 Million	280,965 Added 153.48%	464,024 $44.6 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $16.4 Million - $20.5 Million	-241,941 Reduced 56.93%	183,059 $15.3 Million
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $43.6 Million - $49.2 Million	-649,555 Reduced 60.45%	425,000 $28.7 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $5.05 Million - $5.9 Million	-101,220 Reduced 8.61%	1,074,555 $62.2 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $35.3 Million - $39.7 Million	742,914 Added 171.63%	1,175,775 $60.8 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $6.22 Million - $6.97 Million	132,861 Added 44.29%	432,861 $0
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $13.9 Million - $15.8 Million	300,000 New	300,000 $0

Others Institutions Holding NVO

# of Institutions

1,882

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $201B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Account

Alyeska Investment Group, L.P. Novo Nordisk A S Transaction History